保寶龍科技(01861.HK)年度淨利為3741.2萬港元 同比減10.25%
格隆匯3月23日丨保寶龍科技(01861.HK)公告,截至2019年12月31日止年度的年度業績,收益5.61億港元,同比減8.08%;母公司擁有人應占溢利3741.2萬港元,同比減10.25%;母公司普通權益持有人應占每股盈利16.0港仙。
於報告期內,集團汽車美容及保養產品分部錄得營業額較2018年同期增加約4.5%。分部收益增加主要由於實施銷售策略以提高帶動分部銷售增加的品牌的知名度。
毛利增加主要是受銷售毛利較高的產品組合及生產的主要原材料溶劑的採購成下跌帶動。毛利率增加至約29.2%(2018年:約25.8%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.